Thymogen as an adjunct in inflammatory gynecological conditions
Observational study · 1992
- What was studied
- 46 patients with acute endomyometritis, exacerbated chronic salpingo-oophoritis or purulent tubo-ovarian disease received adjunctive Thymogen.
- Main finding
- A 46-patient report describes lymphocyte counts moving toward reference values and higher T-cell functional activity during combined care.
Reported findings and study design
Findings described in words
Historical adjunctive treatment report across several gynecological diagnoses.
Population or model 46 patients with acute endomyometritis, exacerbated chronic salpingo-oophoritis or purulent tubo-ovarian disease received adjunctive Thymogen.
Protocol information
The indexed abstract gives no dose, administration route, duration or companion drug schedules.
Protocol source ↗ · Original indexed abstract, cohort and reported immune outcomes.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Lymphocyte indices | Authors report normalization of lymphocyte counts and higher T-cell functional activity | |
| Reported complications | None described in the abstract | The abstract gives no adverse-event ascertainment method. |
Source for these results ↗ · Reviewed 2026-11-15
Study limitations and source details
Study limitations
- The abstract gives no comparator denominator or numeric changes and does not establish Thymogen’s independent effect.
Source details
Original indexed abstract, cohort and reported immune outcomes.
Sources checked
Citation
Iu. V. Tsvelev, V. Kh. Khavinson, A. V. Diachuk, A. V. Gur’ev, S. V. Seryĭ. Thymogen as an adjunct in inflammatory gynecological conditions Akusherstvo i Ginekologiia (Moscow). 1992;(2):54–57.